Hormonal therapy options for prostate-specific antigen-only recurrence of prostate cancer after previous local therapy.
Moul
Judd W
JW
Division of Urologic Surgery and Duke Prostate Cancer, Duke University, Durham, NC 27710, USA. Judd.Moul@duke.edu
Zlotta
Alexandre R
AR
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000188:drug therapy*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen